Search research articles
Contact Us
Filters
Showing results (41-50 of 144) with videos related to
Page
of 15
Sort By:
Progress in Clinical and Biological Research
|
January 1, 1990
M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) and bladder preservation
H Scher, H Herr, C Sternberg, et al.
Progress in Clinical and Biological Research
|
January 1, 1990
The prognostic value of the pT-category after combination chemotherapy for patients with invasive bladder cancer who underwent cystectomy. EORTC-GU group
T A Splinter, H I Scher, L Denis, et al.
The American Journal of Medicine
|
March 1, 1985
Role of etoposide-based chemotherapy in the treatment of patients with refractory or relapsing germ cell tumors
G J Bosl, A Yagoda, R B Golbey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 21, 2006
Assessing interactions between mdm-2, p53, and bcl-2 as prognostic variables in muscle-invasive bladder cancer treated with neo-adjuvant chemotherapy followed by locoregional surgical treatment
F C Maluf, C Cordon-Cardo, D A Verbel, et al.
Cancer Investigation
|
October 19, 2000
Evaluation of drug delivery and survival impact of dose-intense relative to conventional-dose methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy in urothelial cancer
P M Dodd, J A McCaffrey, M Mazumdar, et al.
British Journal of Urology
|
September 1, 1989
Neo-adjuvant chemotherapy for invasive bladder cancer. Experience with the M-VAC regimen
H Scher, H Herr, C Sternberg, et al.
Urologic Oncology
|
January 14, 2011
Updated concepts and treatment of carcinoma in situ
D Lamm, H Herr, G Jakse, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
April 1, 1971
Distribution of systemic blood flow of the rhesus monkey during cardiopulmonry bypass
M H Lees, R H Herr, J D Hill, et al.
Seminars in Urology
|
August 1, 1990
Neoadjuvant chemotherapy for bladder cancer: the MSKCC experience
W R Fair, H Scher, H Herr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 15, 1998
Treatment of patients with transitional-cell carcinoma of the urothelial tract with ifosfamide, paclitaxel, and cisplatin: a phase II trial
D F Bajorin, J A McCaffrey, S Hilton, et al.
Page
of 15
Search research articles
Search
Showing results (41-50 of 144) with videos related to
Sort By:
Page
of 15
Progress in Clinical and Biological Research
|
January 1, 1990
M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) and bladder preservation
H Scher, H Herr, C Sternberg, et al.
Progress in Clinical and Biological Research
|
January 1, 1990
The prognostic value of the pT-category after combination chemotherapy for patients with invasive bladder cancer who underwent cystectomy. EORTC-GU group
T A Splinter, H I Scher, L Denis, et al.
The American Journal of Medicine
|
March 1, 1985
Role of etoposide-based chemotherapy in the treatment of patients with refractory or relapsing germ cell tumors
G J Bosl, A Yagoda, R B Golbey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 21, 2006
Assessing interactions between mdm-2, p53, and bcl-2 as prognostic variables in muscle-invasive bladder cancer treated with neo-adjuvant chemotherapy followed by locoregional surgical treatment
F C Maluf, C Cordon-Cardo, D A Verbel, et al.
Cancer Investigation
|
October 19, 2000
Evaluation of drug delivery and survival impact of dose-intense relative to conventional-dose methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy in urothelial cancer
P M Dodd, J A McCaffrey, M Mazumdar, et al.
British Journal of Urology
|
September 1, 1989
Neo-adjuvant chemotherapy for invasive bladder cancer. Experience with the M-VAC regimen
H Scher, H Herr, C Sternberg, et al.
Urologic Oncology
|
January 14, 2011
Updated concepts and treatment of carcinoma in situ
D Lamm, H Herr, G Jakse, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
April 1, 1971
Distribution of systemic blood flow of the rhesus monkey during cardiopulmonry bypass
M H Lees, R H Herr, J D Hill, et al.
Seminars in Urology
|
August 1, 1990
Neoadjuvant chemotherapy for bladder cancer: the MSKCC experience
W R Fair, H Scher, H Herr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 15, 1998
Treatment of patients with transitional-cell carcinoma of the urothelial tract with ifosfamide, paclitaxel, and cisplatin: a phase II trial
D F Bajorin, J A McCaffrey, S Hilton, et al.
Page
of 15